Evaluation of quality of recovery after general anesthesia with isoflurane compared with propofol in abdominal hysterectomy
Phase 3
Recruiting
- Conditions
- Quality of recovery in abdominal hysterectomy.Other complications of anesthesiaT88.59
- Registration Number
- IRCT20110409006148N5
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
80 female patients 30 to 65 years old with 1 and 2 stages of health based on American Society of Anesthesiologists(ASA) who are candidates for abdominal hysterectomy
Exclusion Criteria
Body Mass Index more than 30 kg/m2
Difficult airway
Psychotic disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of recovery. Timepoint: 24 hours before surgery-24 hours after surgery-48 hours after surgery. Method of measurement: Questionnaire of quality of recovery-15.;Post operative pain. Timepoint: 24 hours before surgery-24 hours after surgery-48 hours after surgery. Method of measurement: Questionnaire of quality of recovery-15.;Nausea and vomiting. Timepoint: 24 hours before surgery-24 hours after surgery-48 hours after surgery. Method of measurement: Questionnaire of quality of recovery-15.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie isoflurane and propofol's effects on postoperative recovery quality in abdominal hysterectomy (IRCT20110409006148N5)?
How does isoflurane compare to propofol for postoperative cognitive function and recovery time in abdominal hysterectomy (IRCT20110409006148N5)?
Which biomarkers predict better recovery outcomes with isoflurane versus propofol in abdominal hysterectomy patients (IRCT20110409006148N5)?
What adverse events are linked to isoflurane and propofol in abdominal hysterectomy (IRCT20110409006148N5) and their management strategies?
How does isoflurane's recovery quality compare to other inhalational anesthetics in phase III abdominal hysterectomy trials (IRCT20110409006148N5)?